• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

NxThera Inc.

Feds indict ex-Acclarent execs | The week in medtech M&A

April 15, 2015 By MassDevice Leave a Comment

Feds slap former Acclarent execs with fraud charges

April 13, 2015 by Brad Perriello

Filed Under: Mergers & Acquisitions, News Well Tagged With: Acclarent Inc., Apple, Biomet, EarLens, Ethicon, Explorys, Federal Trade Commission (FTC), IBM, Johnson and Johnson, NxThera Inc., Phytel, Zimmer Biomet

Feds slap former Acclarent execs with fraud charges

April 13, 2015 By Brad Perriello Leave a Comment

Feds slap former Acclarent execs with fraud charges

Federal prosecutors last week leveled conspiracy and fraud charges against 2 former executives of Acclarent for an alleged off-label marketing scheme for the Relieva Stratus microflow spacer.

Filed Under: Legal News, Mergers & Acquisitions, News Well Tagged With: Acclarent Inc., EarLens, Ethicon, Johnson and Johnson, NxThera Inc.

RIP former Evalve CEO Powell | Personnel Moves

March 23, 2015 By Brad Perriello Leave a Comment

RIP former Evalve CEO Powell | Personnel Moves

Former Evalve CEO Ferolyn Powell, who led the MitraClip developer to a $410 million acquisition by Abbott (NYSE:ABT), died this month in a motorbike accident in northern Thailand, her family said yesterday.

Filed Under: News Well Tagged With: Abbott, C.R. Bard, Cantel Medical Corp., Clayton Dubilier Rice, Evalve, InVivo Therapeutics, JP Morgan Chase, Masimo, NxThera Inc., Personnel Moves, Spectranetics Corp., SurModics Inc., Urologix Inc.

More changes at Hologic as it axes administrative chief Casey | Personnel Moves

November 20, 2014 By Brad Perriello Leave a Comment

More changes at Hologic as it axes administrative chief Casey | Personnel Moves

Filed Under: Medical Device Manufacturers Assn. (MDMA), News Well Tagged With: Acelity, Cheetah Medical, Cor Medical Technologies, Dynatronics Corp, Hologic, Invacare, MELA Sciences Inc., NxThera Inc., Personnel Moves, Vision-Ease Lens

Medtech funding for the week of Mar. 3, 2014

March 7, 2014 By MassDevice staff Leave a Comment

EarLens pulls in $36M for infrared hearing aid

March 3, 2014 by Brad Perriello

EarLens gains $36M

EarLens said it raised some $36 million in an equity round for the hearing aid technology it’s developing that uses infrared rather than sound waves.

Filed Under: Funding Roundup, News Well Tagged With: Ascension Health Ventures, Benvenue Medical Inc, Cheetah Medical, EarLens, Fletcher Spaght Ventures, Invuity, MVM Life Science Partners, NxThera Inc., Robert Bosch Venture Capital, Springfield Investments

NxThera closes $20M Series C round

March 4, 2014 By Brad Perriello Leave a Comment

NxThera closes $20M Series C financing round

NxThera said it closed a $20 million Series C round that topped its initial $18 million target.

Maple Grove, Minn.-based NxThera won CE Mark approval in the European Union last August for its Rezūm prostate device, which uses steam to reduce the size of the prostate to relieve urinary symptoms from benign prostate hyperplasia.

Filed Under: Funding Roundup, News Well Tagged With: Minnesota, NxThera Inc., Prostate

NxThera closes $18M Series C, wins CE Mark for Rezum prostate device

August 15, 2013 By Brad Perriello Leave a Comment

NxThera closes $18M Series C, wins CE Mark for Rezum prostate device

NxThera said it closed on a Series C round worth $18.2 million and won CE Mark approval for its Rezum treatment for benign prostatic hyperplasia.

Maple Grove, Minn.-based NxThera’s device uses steam to reduce the size of the prostate to relieve urinary symptoms from BPH, according to NxThera’s website.

Filed Under: Funding Roundup, News Well Tagged With: Minnesota, NxThera Inc., Prostate, Venture Capital/Private Equity

Medtech funding: NxThera raises $3.5 million

April 11, 2013 By Brad Perriello Leave a Comment

MassDevice.com Funding Roundup

NxThera reported raising $3.5 million in an April 4 regulatory filing:

Company: NxThera
Raise: $3.5 million
Security: Debt; Options/Warrants
Investors: 17
Sales Commission: $0
Finders’ Fees:$0

Filed Under: Funding Roundup, News Well Tagged With: NxThera Inc.

Entegrion lands $43.7 million DOD deal | Funding Roundup

October 5, 2011 By MassDevice staff Leave a Comment

Entegrion

Entegrion landed a $43.7 million dollar contract with the Dept. of Defense for its Resusix proprietary dehydrated pathogen-inactivated human plasma.

Resusix holds promise as a substitute for fresh frozen plasma in certain situations. The Defense Dept. contract will fund Resusix’s development through Phase III clinical trials and biological license application.

Filed Under: Blood Management, Funding Roundup, News Well Tagged With: defensedepartment, Dept. of Health & Human Services (HHS), Entegrion Inc., Image Stream Medical Inc., NxThera Inc., TearScience

Thermalin Diabetes snaps up $2.9 million in A round | Funding roundup

March 29, 2011 By MassDevice staff Leave a Comment

Funding Roundup

Startup Thermalin Diabetes LLC closed a $2.85 million Series A investment round.

The Cleveland-based synthetic insulin developer plans to use the funding to step up production of its insulin analogs — new proteins engineered to act like insulin in the body — and continue preclinical testing.

Filed Under: News Well Tagged With: ConvaTec, Ingenious Med Inc., NxThera Inc., Teleflex, Thermalin Diabetes LLC

NxThera’s mystery backer is American Medical Systems

March 17, 2011 By MedCity News Leave a Comment

NxThera, AMMD

Word is out about the identity of the corporate partner NxThera CEO Robert Paulson mentioned last week: American Medical Systems Inc. (NSDQ:AMMD).

AMS specializes in medical devices related to pelvic health. NxThera is developing a thermal vapor prostate treatment that involves the same area of the body where American Medical Systems’ expertise lies.

Filed Under: News Well Tagged With: American Medical Systems Holdings Inc., NxThera Inc., Venture Capital/Private Equity

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS